SCHEMBL9762596

SCHEMBL9762596

Nc1c([N+](=O)[O-])n[nH]c1O

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8150180 0.80 CCNE2 (0.38) MAPT
SCHEMBL3636660 0.77 MAPT (0.33) MAPT
SCHEMBL2457899 0.77 MAPT (0.33) MAPT
Potassium SCHEMBL31289361 0.75 LMNA (0.33) MAPT
Ammonia Solution, Strong SCHEMBL28953858 0.75 MAPT (0.33) MAPT
SCHEMBL27825850 0.75 MAPT (0.33) MAPT
SCHEMBL12335171 0.75 CCNE2 (0.38) MAPT
Ammonia Solution, Strong SCHEMBL30504109 0.73 MAPT (0.32) MAPT
SCHEMBL3632711 0.68 MAPT (0.32) MAPT
SCHEMBL2456150 0.68 CCNE2 (0.36) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2130821-B1 Derivatives of 3,4,5-trinitropyrazole, their preparation and the energetic compositions containing them SME (FR) 2011-09-21 EP disclosed
US-5026694-A Antitumor agents THE BRITISH COLUMBIA CANCER FOUNDATION (CA) 1991-06-25 US disclosed